If this message board is any indication, I have never before owned a stock doing as well as this one, and continues to fly under the radar. One analyst subsequent to attending Investor day wrote that this company's equipment could at some point become a part of the Standard of Care on a number of different operations. The implications of such an event are considerable.
Forget the analyst - the 1st surgeon at the conference said there were very few surgeries that wouldn't benefit from this technology, as most complications are due to some form of necrosis or leakage that could be avoided by using Spy.
I'm a little confused. Why would I want to forget an analyst who makes such a powerful positive statement. As I understand it once equipment is deemed the standard of care for a particular type of surgery, a surgeon would take on real risk in performing the operation without using the equipment.
While the value of the equipment may be applicable to all surgeries, it is a little too soon to hope that it becomes the standard of care for all surgeries. However, having watched the presentations, the importance of this equipment in breast reconstruction is so overwhelming that having it designated as standard of care for this type of surgery could happen in the not to distant future.